Elon Musk’s Drug Use Allegations Puts Personal Conduct On Board Agendas
The possibility of a CEO using or abusing illegal substances or prescription drugs presents several questions for the boardroom.
The possibility of a CEO using or abusing illegal substances or prescription drugs presents several questions for the boardroom.
C-Suites will soon be responsible for integrating modern sustainability strategies within their organizations’ financial reporting—and boards will be responsible for oversight—but many don’t know where to start or how to track emissions.
Unless the answer is a definitive “no,” the time is now to lay the groundwork for the reporting requirements.
Whereas regular evaluations of market risks and opportunities are likely baked into board meetings, an examination of the broader regulatory landscape in which a company operates can easily be overlooked. Here’s how to get ahead of a coming storm.
Following are some of the ways companies are showcasing board strengths in their proxies as well as IR messaging.
The board’s failure to take swift action could result in shareholder lawsuits, an SEC investigation and loss of insurance protection.
Chief Executive Group exists to improve the performance of U.S. CEOs, senior executives and public-company directors, helping you grow your companies, build your communities and strengthen society. Learn more at chiefexecutivegroup.com.